Nordmark Pharma GmbH

General information
Nordmark Pharma GmbH
Pinnauallee 4
25436 Uetersen, Schleswig-Holstein
Germany

Contact person: Jörn Ton, Managing Director & CEO
Company main phone: +49 (4122) 7120
Company main fax:  +49 (4122) 712220
Website:  https://www.nordmark-pharma.de
Year founded:2001
Source of foundation:Management buy-out (MBO)
Name of foundation source:BASF Group
Corporate description / mission:
Nordmark are specialists in the manufacture of active pharmaceutical ingredients and drug products of biological origin. The pharmaceutical products in Nordmark’s product portfolio contain active ingredients produced in-house, such as pancreatin, heparin and Pepsin. The company's technologies include the extraction of biological raw materials (e.g. for obtaining the enzyme pancreatin), microbial fermentation (e.g. collagenase for isolating stem cells) and the extraction of active ingredients from cell cultures (e.g. for antibodies).
State of ownership: Private / independent
Headquarters: HQ: Yes
Categorization
Sector:
  • Biotechnology - R&D Services
Subsector:
  • Analytical services
  • Cell culture
  • CMO (Contract Manufacturing Organization)
  • Proteomics
Business model:
  • Manufacturer
  • R&D
  • Service company
  • Supplier / Distributor
Customer segments:
  • Large biotech & big pharma
  • Small biotech
Distribution:
  • Direct (own sales force)
Summary Products / Services / Technologies
Description of products:
Products:

Collagenase NB
Pancreatin powder
Pancreatin pellets, etc.

Services:

Development/optimisation of strains or cell cultures
Fermentation
Protein purification
Scale-up
Development of the formulation
Manufacture of clinical samples
Support in clinical trials and regulatory discussions.
X